New Alzheimer’s Prevention Trial in Young People

New Alzheimer’s Prevention Trial in Young People Washington University School of Medicine in St. Louis is launching an international clinical trial aimed at preventing Alzheimer’s disease in people genetically destined to develop the illness at a young age. Unlike most other Alzheimer’s prevention trials, this one will enroll people before

Improving Drug Options for Colorectal Cancer Patients

Improving Drug Options for Colorectal Cancer Patients Patients with colorectal cancer were among the first to receive targeted therapies. These drugs aim to block the cancer-causing proteins that trigger out-of-control cell growth while sparing healthy tissues. But some patients are not eligible for these treatments because they have cancer-promoting mutations

Antipsychotic Drugs May Increase Risk of Breast Cancer

Antipsychotic Drugs May Increase Risk of Breast Cancer Tracking medications provided to over a half million U.S. women, researchers at Washington University School of Medicine in St. Louis have found that many commonly prescribed older antipsychotic medications, and some newer ones, are associated with a significant increase in risk of

Type 1 Diabetes: Study Uncovers New Avenue Toward Treatment

Type 1 Diabetes: Study Uncovers New Avenue Toward Treatment Scientists have already implicated a particular part of a chromosome in type 1 diabetes. However, they did not understand exactly why this region — known as locus 3p21.31 — influences risk. The current study adds more detail. Read more...

Cancer Moonshot Grant Funds Research Into Reducing Health Disparities

Cancer Moonshot Grant Funds Research Into Reducing Health Disparities Washington University School of Medicine in St. Louis has received a $17 million grant from the National Institutes of Health (NIH) to address disparities in cancer research, treatment and outcomes in underrepresented populations. The research, funded through the National Cancer Institute’s

Scientists Reveal How Alzheimer’s Progresses in the Brain

Scientists Reveal How Alzheimer’s Progresses in the Brain In people with Alzheimer’s, plaques of a misfolded protein called beta-amyloid, and fibrous tangles of another misfolded protein called tau, accumulate in the brain and kill nerve cells. This gradual loss of nerve cells causes shrinkage of the brain and eventually interferes

Go to Top